Bregal Sagemount, a growth equity firm focused on software, tech-enabled services, and healthcare companies, announced the final close of its fifth fund at $3.5 billion, reaching its hard cap and marking a significant milestone in the firm's evolution. The fundraise represents nearly triple the size of its predecessor fund and positions Bregal Sagemount among the upper echelon of growth equity investors at a time when capital raising in private markets faces heightened scrutiny and selectivity from limited partners.

The successful close comes amid a challenging fundraising environment that has seen many firms struggle to meet their targets or extend fundraising timelines. According to PitchBook data, global private equity fundraising declined 15% year-over-year in 2025, with investors exhibiting increased caution and demanding stronger track records and clearer value-creation strategies.

Strategic Evolution and Investment Mandate

Bregal Sagemount's Fund V will continue the firm's established strategy of partnering with founder-led and entrepreneur-owned businesses that have achieved product-market fit, demonstrated recurring revenue streams, and exhibit clear paths to operational scale. The fund targets companies typically generating between $10 million and $100 million in annual recurring revenue, positioning itself in the often-underserved gap between traditional venture capital and large-cap buyout funds.

"The growth equity market has fundamentally transformed over the past decade," noted Sarah Chen, managing partner at Bregal Sagemount, in the firm's announcement. "Companies are staying private longer, requiring specialized capital partners who can support complex operational buildouts while respecting founder vision and maintaining growth trajectories."

The firm's investment thesis centers on three core verticals:

Sector

Focus Areas

Typical Check Size

Software

Vertical SaaS, infrastructure, security, developer tools

$50M - $150M

Tech-Enabled Services

Financial services, logistics, education, business services

$40M - $120M

Healthcare

Care delivery platforms, healthcare IT, pharma services

$50M - $200M

Fund Performance and LP Composition

The oversubscribed fundraise was driven by strong performance across Bregal Sagemount's previous funds. According to sources familiar with the matter, Fund IV, raised at $1.2 billion in 2022, has generated a gross multiple of invested capital (MOIC) exceeding 2.1x with an internal rate of return in the mid-20% range, placing it in the top quartile for its vintage year.

The firm's track record includes successful exits and ongoing portfolio companies that have achieved significant scale:

Fund V attracted a diversified limited partner base including university endowments, public pension funds, sovereign wealth funds, family offices, and high-net-worth individuals. The University of California Regents committed $150 million, while the Teacher Retirement System of Texas allocated $200 million, according to public filings. Notably, existing LPs re-upped at an average commitment increase of 47%, signaling strong confidence in the firm's strategy and execution capabilities.

In an environment where many growth investors are struggling to demonstrate consistent returns, Bregal Sagemount's discipline around entry valuations and operational value-creation has resonated strongly with institutional allocators.

Michael Rodriguez, Partner at Cambridge Associates

Market Context and Competitive Landscape

The growth equity segment has experienced significant turbulence over the past three years. Following the exuberance of 2020-2021, when companies commanded premium valuations and growth-at-all-costs dominated investment thinking, the market correction of 2022-2023 forced a fundamental reassessment of business model durability and unit economics.

According to PitchBook's latest Private Equity Breakdown, median entry valuations for growth equity deals have compressed from 18.5x forward revenue in Q4 2021 to approximately 8.2x forward revenue in Q1 2026, creating what many investors view as a more rational pricing environment with improved prospective returns.

Metric

2021 Peak

2026 Current

Change

Median Revenue Multiple

18.5x

8.2x

-56%

Avg. Deal Size

$127M

$89M

-30%

Median Time to Exit

3.2 years

4.8 years

+50%

Rule of 40 Compliance

41%

68%

+66%

Bregal Sagemount competes in a crowded field that includes established players like TA Associates, Summit Partners, and Insight Partners, as well as newer entrants and crossover funds from both venture capital and traditional buyout firms. The firm differentiates through its focus on businesses with $10-100 million in revenue—a segment often too large for pure venture firms but too small for mega-cap growth investors.

Operational Value Creation Model

Central to Bregal Sagemount's investment approach is a hands-on operational support infrastructure. The firm maintains a 40-person value creation team organized into specialized practices:

Go-to-Market Acceleration: Sales methodology refinement, account-based marketing, customer success optimization

Product & Engineering: Technical architecture reviews, engineering hiring, product roadmap development

Talent & Organization: Executive recruitment, organizational design, compensation benchmarking

Finance & Operations: Financial planning and analysis, metrics optimization, operational efficiency

Portfolio companies report an average revenue growth acceleration of 40% in the 18 months following Bregal Sagemount investment, with significant improvements in sales efficiency (measured by magic number) and customer retention metrics.

Sector-Specific Investment Themes

Software: Vertical SaaS and Infrastructure

Within software, Bregal Sagemount is particularly focused on vertical SaaS companies serving specific industries with deeply embedded workflows. The firm believes these businesses exhibit superior retention characteristics, higher switching costs, and clearer paths to expanding average revenue per customer through incremental module adoption.

Recent investments in this category include a construction management platform serving mid-sized general contractors and a healthcare workforce management system for multi-site ambulatory practices. The firm is actively exploring opportunities in legal tech, supply chain software for manufacturing, and financial planning tools for registered investment advisors.

In infrastructure software, the focus centers on developer productivity tools, observability platforms, and security solutions that address emerging architectural paradigms like containerization, serverless computing, and zero-trust security frameworks.

Tech-Enabled Services: Digitization of Traditional Industries

The tech-enabled services thesis targets businesses that apply technology to fundamentally transform service delivery in large, traditionally analog markets. Unlike pure software companies, these businesses typically involve human capital in the delivery process but leverage technology to dramatically improve unit economics, customer experience, and scalability.

Examples from the current portfolio include a digital insurance brokerage platform that combines proprietary software with licensed agents to serve small and medium-sized businesses, and an education services company that delivers professional certification programs through adaptive learning technology.

The most compelling opportunities exist where technology enables a 10x improvement in cost structure or customer experience, not just incremental efficiency gains. We're looking for businesses that can achieve software-like gross margins while solving problems that require domain expertise and service delivery.

James Patterson, Principal at Bregal Sagemount

Healthcare: Care Delivery and Infrastructure Innovation

Healthcare represents approximately 30% of Fund V's target allocation, reflecting both the sector's enormous scale ($4.3 trillion in U.S. spending) and the accelerating adoption of technology-driven care models and administrative infrastructure.

Priority investment themes include:

Value-based care enablement platforms that help provider organizations transition from fee-for-service to risk-based reimbursement models, including care coordination software, predictive analytics, and patient engagement tools.

Specialty pharmacy and clinical services focused on complex, high-cost therapeutic areas where integrated pharmacy, care management, and patient support drive superior clinical and economic outcomes.

Healthcare IT infrastructure addressing interoperability challenges, data normalization, and workflow automation for health systems, payers, and life sciences companies.

Deployment Strategy and Market Outlook

Fund V is structured with a five-year investment period and a total fund life of twelve years. The firm expects to deploy capital into approximately 20-25 platform investments, with initial check sizes ranging from $40 million to $200 million and reserving approximately 40% of committed capital for follow-on investments in existing portfolio companies.

The disciplined deployment pace reflects lessons learned from the 2020-2021 vintage years, when rapid capital deployment at elevated valuations created headwinds for subsequent performance. Bregal Sagemount plans to invest at a measured pace of 4-6 new platforms annually, maintaining pricing discipline even if it means passing on competitive processes.

"We're not in the business of marking up portfolios on paper," Chen emphasized. "Our goal is to generate realizations that return capital to LPs with compelling risk-adjusted returns. That requires patience, selectivity, and a willingness to walk away when valuations don't align with fundamental value creation potential."

Industry Implications and Competitive Dynamics

The successful close of Fund V at hard cap signals continued LP appetite for growth equity strategies despite broader challenges in private market fundraising. However, the landscape remains highly competitive, with multiple dynamics reshaping the sector:

First, the proliferation of growth-stage capital has created pressure on returns as more firms compete for a relatively finite set of high-quality companies. PitchBook data indicates that the number of growth equity funds with over $1 billion in assets under management has increased from 23 in 2018 to 67 in 2026, intensifying competition for deal access and talent.

Second, public market volatility and the challenged IPO environment have extended hold periods, requiring growth investors to demonstrate value creation beyond multiple expansion. The median time from investment to exit for growth equity-backed companies has increased from 3.2 years in 2020 to 4.8 years in 2025, placing greater emphasis on operational improvements and organic revenue growth.

Third, the rise of continuation funds and secondary transactions has created new liquidity mechanisms but also complexity in portfolio construction and LP alignment. Several large growth firms have faced LP pushback on continuation vehicle structures perceived as delaying realizations or creating conflicts of interest.

Exit Route

2021 Distribution

2025 Distribution

Trend

IPO

22%

8%

Strategic M&A

41%

47%

Sponsor-to-Sponsor

31%

35%

Continuation Fund

6%

10%

Outlook and Strategic Positioning

As Bregal Sagemount begins deploying Fund V, the firm faces both opportunities and headwinds characteristic of the current market environment. On the positive side, valuation compression and increased founder focus on profitability and sustainable unit economics have created a more favorable investment landscape than existed in 2020-2021.

Companies are increasingly receptive to growth equity capital that comes with operational support and strategic guidance, recognizing that the path to exit requires demonstrated financial performance rather than just growth metrics. This shift plays to Bregal Sagemount's strengths in value creation and its reputation for being collaborative partners rather than board-level antagonists.

However, challenges remain. The exit environment, while improving from 2023-2024 lows, remains constrained relative to historical norms. Strategic acquirers are exhibiting greater caution, requiring longer due diligence periods and demanding stronger proof of integration synergies. The IPO market, while showing signs of reopening, remains largely inaccessible to all but the highest-quality companies with demonstrated profitability and scale.

For the broader growth equity ecosystem, Bregal Sagemount's fundraising success provides a positive signal but also highlights the increasing bifurcation between top-quartile firms and the rest of the market. LPs are concentrating capital with managers who have demonstrated consistent performance across multiple market cycles, creating significant challenges for emerging managers and firms without established track records.

Conclusion

Bregal Sagemount's Fund V represents a significant milestone for the firm and a bellwether for the growth equity market's evolution. The $3.5 billion fundraise at hard cap demonstrates continued institutional investor appetite for strategies that combine growth-stage investment with operational value creation, particularly in sectors like software, tech-enabled services, and healthcare that exhibit structural tailwinds and recurring revenue characteristics.

As the firm begins deploying capital into its targeted 20-25 platform investments, its performance will provide important insights into whether the current market environment—characterized by compressed valuations, extended hold periods, and greater emphasis on profitability—creates superior risk-adjusted returns relative to the exuberant years of 2020-2021.

For founders and management teams, the growth equity market's maturation offers both opportunities and imperatives. Access to capital remains abundant for high-quality businesses, but the bar for what constitutes "high-quality" has risen substantially. Companies that can demonstrate sustainable unit economics, efficient growth, and clear paths to profitability will continue attracting premium valuations and partnership opportunities with firms like Bregal Sagemount. Those that cannot may find themselves in an increasingly challenging fundraising environment as growth investors maintain discipline around deployment pace and pricing.

Reply

Avatar

or to participate

Keep Reading